1. U.S. Food and Drug and Administration (US). Science guides Alzheimer’s disease drug development [Internet]. Bethesda, MD: U.S. Department of Health and Human Services, Food and Drug Administration; [updated 2014 Dec 5; cited 2015 Feb 8]. Available from: http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm361513.htm
2. Alzheimer’s Association, Gaugler J, James B, Johnson T, Scholz K, Weuve J. Facts and figures includes a special report on women and Alzheimer’s Disease [Internet]. Chicago, IL: Alzheimer’s Association, Main Office; 2014 [cited 2015 February 8]. Available from: http://www.alz.org/downloads/Facts_Figures_2014.pdf?utm_content=bufferb49b5&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
3. Petrella JR. Neuroimaging and the search for a cure for Alzheimer disease. Radiology. 2013;269(3):671–91.
4. Becker RE, Greig NH. Lost in translation: neuropsychiatric drug development. Sci Transl Med. 2010;2(61):61rv6.
5. Caraci F, Bosco P, Leggio GM, Malaguarnera M, Drago F, Bucolo C, Salomone S. Clinical pharmacology of novel anti-Alzheimer disease modifying medications. Curr Top Med Chem. 2013;13(15):1853–63.